Ackman sold 16.85 million Zoetis shares at an average price of
$46.55 each, the filing showed on Tuesday.
The fund had reported an 8.6 percent stake in the company in a
filing on April 22.
Zoetis, which was spun off from Pfizer Inc in 2013, reported
better-than-expected quarterly revenue and profit last week.
Pershing Square was a top industry performer in 2014, when it
delivered a 40 percent return. But more recently it has been
close to the bottom, losing 20 percent last year.
(Reporting by Natalie Grover in Bengaluru; Editing by Saumyadeb
Chakrabarty)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|
|